¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"central necrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal papillary necrosis
    ÄáÆÏÀ¯µÎ±«»ç, ½ÅÀåÀ¯µÎ±«»ç
  • subacute hepatic necrosis
    ¾Æ±Þ¼º°£±«»ç
  • subcutaneous fat necrosis
    ÇǺιØÁö¹æ±«»ç, ÇÇÇÏÁö¹æ±«»ç
  • zonal necrosis
    ±¸¿ª±«»ç
  • central
    Áß½É-, ÁßÃß-
  • central amaurosis
    ÁßÃß¼ºÈæ¾Ï½Ã
  • central aphasia
    ÁßÃß¾ð¾î»ó½ÇÁõ, ÁßÃ߽ǾîÁõ
  • central artery
    Á߽ɵ¿¸Æ
  • central ataxia
    ÁßÃß½ÇÁ¶
  • central attachment
    Á߽ɺÎÂø
  • central auditory processing disorder
    ÁßÃßû°¢Ã³¸®Àå¾Ö
  • central callus
    Á߽ɾֹú»À, Á߽ɰ¡°ñ
  • central canal
    Á߽ɰü
  • central cataract
    Á߽ɹ鳻Àå
  • central chemoreceptor
    ÁßÃßÈ­Çмö¿ëü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • subcutaneous fat necrosis
    ÇǺιØÁö¹æ±«»ç, ÇÇÇÏÁö¹æ±«»ç
  • traumatic fat necrosis
    ¿Ü»óÁö¹æ±«»ç
  • tubular necrosis
    ¿ä¼¼°ü±«»ç
  • central amaurosis
    ÁßÃßÈæ¾Ï½Ã
  • central aphasia
    ÁßÃß¾ð¾î»ó½ÇÁõ
  • central artery
    Á߽ɵ¿¸Æ
  • central ataxia
    ÁßÃßÁ¶È­¿îµ¿ºÒ´É
  • central attachment
    Á߽ɺÎÂø
  • central retinal artery
    ¸Á¸·Á߽ɵ¿¸Æ
  • central visual acuity
    Á߽ɽ÷Â
  • central
    Áß½É-, ÁßÃß-
  • central callus
    Á߽ɾֹú»À
  • central canal
    Á߽ɰü
  • central cataract
    Á߽ɹ鳻Àå
  • central chemoreceptor
    ÁßÃßÈ­Çмö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal papillary necrosis
    ½ÅÀ¯µÎ±«»ç(¡­ÎÕÞÝ).
  • renal papillary necrosis
    ½ÅÀ¯µÎ±«»ç(ãìêáÔéÎÕÞÝ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • focal necrosis
    ±¹¼Ò±«»ç
  • gangrenous necrosis
    ±«Àú¼º±«»ç
  • gangrenous necrosis
    ±«Àú¼º ±«»ç(¡­ÎÕÞÝ)
  • hyaline necrosis
    À¯¸®¾ç ±«»ç
  • ischemic cortical necrosis
    ÇãÇ÷¼º ÇÇÁú±«»ç(¡­ù«òõÎÕÞÝ).
  • kidney,diffuse cortical necrosis
    ¹Ì¸¸¼ºÇÇÁú±«»ç( Ø·àõù«òõ ÎÕÞÝ)
  • kidney,papillary necrosis
    À¯µÎ±«»ç(êáÔéÎÕÞÝ)
  • kidney,tubular necrosis
    ¼¼´¢°ü ±«»ç(á¬Òãη ÎÕÞÝ)
  • lipolytic necrosis
    Áö¹æ À¶Çؼº ±«»ç
  • liquefaction,necrosis
    ¾×È­±«»ç
  • liquefactive necrosis
    ¾×È­±«»ç
  • liver cell necrosis
    °£¼¼Æ÷ ±«»ç(¡­ÎÕÞÝ)
  • liver necrosis
    °£±«»ç.
  • liver,centrilobular necrosis
    ¼Ò¿± Á߽ɼº ±«»ç(á³ç¨ ¡­)
  • liver,submassive-to-massive necrosis
    ±¤¹ü¼º ±«»ç(ÎÆÛôàõ ¡­)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Central thalamic radiations
    Á߽ɽûóºÎê»ì
    [¿¾ ¿ë¾î] ±Ã½É½Ã»ó¹æ»ç
  • Central thalamic radiations
    Á߽ɽûóºÎê»ì
    [¿¾ ¿ë¾î] Áß½É½Ã»ó¹æ»ç
  • Central gelatinous substance
    Á߽ɾƱ³Áú
    [¿¾ ¿ë¾î] Á߽ɱ³¾çÁú
  • Central fovea
    Á߽ɿÀ¸ñ
    [¿¾ ¿ë¾î] Á߽ɿÍ
  • Central vein
    Áß½ÉÁ¤¸Æ
    [¿¾ ¿ë¾î] Áß½ÉÁ¤¸Æ
  • Central veins
    Áß½ÉÁ¤¸Æ
    [¿¾ ¿ë¾î] Áß½ÉÁ¤¸Æ
  • Central intermediate substance
    Áß½ÉÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£ÁúÁ߽ɺÎ
  • Central nucleus
    Áß½ÉÇÙ
    [¿¾ ¿ë¾î] Áß½ÉÇÙ
  • Central gray (substance)
    Áß½Éȸ»öÁú
    [¿¾ ¿ë¾î] Áß½Éȸ¹éÁú
  • CENTRAL NERVOUS SYSTEM
    ÁßÃ߽Űæ°èÅë
    [¿¾ ¿ë¾î] ÁßÃ߽Űæ°è
  • Central glial cell
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] Á߽ɽŰ汳¼¼Æ÷
  • Glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁßÃß±³¼¼Æ÷
  • Short central artery
    ªÀºÁ߽ɵ¿¸Æ
    [¿¾ ¿ë¾î] ´ÜÁ߽ɵ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AEN aseptic epiphyseal necrosis
ANB avascular necrosis of bone
ASHN acute sclerosing hyaline necrosis
ATN acute tubular necrosis; augmented transition network
AVN acute vasomotor nephropathy; atrioventricular nodal [conduction]; atrioventricular node; avascular n...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TNF Cachectin/tumor necrosis factor
CNV Cucumber necrosis virus
enTNF Endogenous tumor necrosis factor
hTNF-alpha Human Tumor Necrosis Factor-alpha
IPN Infectious Pancreatic Necrosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • central aphasia
    ÁßÃß¼º ½Ç¾îÁõ
  • central areolar choroidal dystrophy
    Á߽ɼº ¿øÇü ¸Æ¶ô¸· ÀÌ¿µ¾ç
  • central artery cerebri mediae
    ÁߺΠ³úµ¿¸Æ Áß½ÉÁö
  • central artery of retina
    ¸Á¸· Á᫐ µ¿¸Æ
  • central attachment
    Á᫐ ºÎÂø
  • central bearing
    Á᫐ ÁöÁö
  • central bearing point
    Á᫐ ÁöÁöÁ¡
    Áß¾Ó ÁöÁö ÀåÄ¡ÀÇ Á¢ÃËÁ¡.
  • central biasing mechanism
    ÁßÃß ±³Â÷ ±âÀü
  • central blister
    Á߽ɼº ¼öÆ÷
  • central body
    Á᫐ ¼Òü
    À¯»çºÐ¿­ Áß¿¡ ¼º»óüÀÇ Á߽ɿ¡ ÀÖ´Â ±¸Á¶¹°.
  • central canal
    Á᫐ °ü
  • central cavernous hemangioma
    Á߽ɼº ÇØ¸é»ó Ç÷°üÁ¾
  • central chemosensitive area
    ÁßÃß È­ÇÐ °¨¼ö ¿µ¿ª
  • central cloudy corneal dystrophy
    Á߽ɼº ȥŹ °¢¸· ÀÌ¿µ¾ç
  • central connection
    Á᫐ ¿¬°á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
total necrosis Complete necrosis of the cytologic and histologic elements in a portion of tissue, as in caseous necrosis, death of an entire organ or part.
(05 Mar 2000)
epiphysial aseptic necrosis Aseptic necrosis of bony epiphyses, probably due to ischemia; it may affect the upper end of the femur (Legg-Calve-Perthes disease), the tibial tubercle (Osgood-Schlatter disease), the tarsal navicular bone or the patella (Kohler's disease), the second metatarsal head (Freiberg's disease), vertebral bodies (Scheuermann's disease), or the capitellum of the humerus (Panner's disease).
(05 Mar 2000)
tumor necrosis factor <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin.
Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine.
Synonym: cachectin.
Acronym: TNF
(13 Nov 1997)
tumour necrosis factor <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin.
Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine.
Synonym: cachectin.
Acronym: TNF
(13 Nov 1997)
tumour necrosis factor-beta <cytokine> A cytolytic factor that is produced by CD4 and CD8 T-cells after their exposure to an antigen.
(05 Mar 2000)
kidney cortex necrosis The death of all the functioning renal cells of the kidney cortex with continued viability of the majority of the medullary units. It is due usually to the arterial distribution peculiar to the kidney which makes the renal cortex more susceptible to diminished blood flow.
(12 Dec 1998)
kidney papillary necrosis A form of acute kidney disease characterised by necrosis of the renal papillae. It is most frequently associated with diabetes mellitus because of the severe vascular disease present in the arteries and capillaries, particularly in the kidney. There is usually a large component of infection present, and in non-diabetics pyelonephritis and obstructive uropathy are the usual aetiologic agents.
(12 Dec 1998)
kidney tubular necrosis, acute Acute kidney failure resulting from destruction of tubular epithelial cells. It is commonly attributed to exposure to toxic agents or renal ischemia following severe trauma.
(12 Dec 1998)
fat necrosis A condition in which the neutral fats in the cells of adipose tissue are split into fatty acids and glycerol.
(12 Dec 1998)
fat necrosis tumour <surgery> Destruction of fat cells in the breast due to trauma or injury that can cause a hard noncancerous lump.
(09 Oct 1997)
Zenker's necrosis A form of severe hyaline degeneration or necrosis in skeletal muscle, occurring in severe infections.
Synonym: waxy degeneration, Zenker's necrosis.
(05 Mar 2000)
zonal necrosis Necrosis predominantly affecting or limited to an anatomical zone, especially parts of the hepatic lobules defined according to proximity to either the portal tracts or central (hepatic) veins.
(05 Mar 2000)
femur head necrosis Aseptic or avascular necrosis of the femoral head. The major types are idiopathic (primary), as a complication of fractures or dislocations, and legg-perthes disease.
(12 Dec 1998)
fibrinoid necrosis Necrosis in which the necrotic tissue has some staining reactions resembling fibrin and becomes deeply eosinophilic, homogenous, and refractile.
(05 Mar 2000)
focal necrosis Occurrence of numerous, relatively small or tiny, fairly well-circumscribed, usually spheroidal portions of tissue that manifest coagulative, caseous, or gummatous necrosis and are characteristically associated with agents that are haematogenously disseminated; frequently observed only in histologic sections, but the foci may be as large as 1 to 3 mm and macroscopically visible; arbitrarily, foci larger than that are usually not termed focal necrosis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á